| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.073 | 0.1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |